DUROLANE is a single-injection, hyaluronic acid product used for joint lubrication in the treatment of pain associated with knee osteoarthritis. (Photo: Business Wire)
HOOFDDORP, The Netherlands--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its exclusive distribution partner for the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190129005082/en/